Get the Stockscreener App
12.88
1.90%
0.24
After Hours:
12.89
0.010
+0.08%
Tyra Biosciences Inc stock is traded at $12.88, with a volume of 214.86K.
It is up +1.90% in the last 24 hours and up +16.46% over the past month.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
See More
Previous Close:
$12.64
Open:
$12.57
24h Volume:
214.86K
Relative Volume:
0.72
Market Cap:
$686.47M
Revenue:
-
Net Income/Loss:
$-83.74M
P/E Ratio:
-8.00
EPS:
-1.61
Net Cash Flow:
$-64.98M
1W Performance:
+25.78%
1M Performance:
+16.46%
6M Performance:
+9.90%
1Y Performance:
-40.54%
1-Day Range:
$12.50
$12.96
1-Week Range:
$9.97
$12.96
52-Week Range:
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
Name
Tyra Biosciences Inc
Sector
Industry
Phone
(619) 728-4760
Address
2656 STATE STREET, CARLSBAD
Compare TYRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
12.88 | 673.68M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-21-25 | Resumed | Piper Sandler | Overweight |
| Jan-07-25 | Initiated | UBS | Buy |
| Oct-18-24 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-15-24 | Initiated | Piper Sandler | Overweight |
| Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-23 | Initiated | Wedbush | Outperform |
| Feb-03-23 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | H.C. Wainwright | Buy |
| Mar-08-22 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-21 | Downgrade | Jefferies | Buy → Hold |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Jefferies | Buy |
View All
Tyra Biosciences Inc Stock (TYRA) Latest News
Can trapped investors hope for a rebound in Tyra Biosciences Inc.Market Weekly Review & Free High Accuracy Swing Entry Alerts - Newser
Is Tyra Biosciences Inc. meeting your algorithmic filter criteriaQuarterly Trade Summary & Free Safe Entry Trade Signal Reports - Newser
Real time social sentiment graph for Tyra Biosciences Inc.2025 EndofYear Setup & High Accuracy Trade Alerts - Newser
Can Tyra Biosciences Inc. hit a new high this month2025 Technical Overview & Expert Verified Stock Movement Alerts - Newser
Will a bounce in Tyra Biosciences Inc. offer an exitWeekly Trend Recap & Technical Confirmation Alerts - Newser
Is Tyra Biosciences Inc. showing signs of accumulation2025 Analyst Calls & Long-Term Safe Investment Plans - Newser
How to manage a losing position in Tyra Biosciences Inc.Market Movement Recap & Risk Controlled Stock Alerts - Newser
Using Ichimoku Cloud for Tyra Biosciences Inc. technicals2025 Growth vs Value & Scalable Portfolio Growth Methods - Newser
Is it too late to sell Tyra Biosciences Inc.Quarterly Trade Summary & Weekly Consistent Profit Watchlists - Newser
Multi factor analysis applied to Tyra Biosciences Inc.2025 Market Outlook & AI Forecasted Entry/Exit Points - Newser
Live market analysis of Tyra Biosciences Inc.July 2025 Retail & Verified Momentum Stock Watchlist - Newser
Ranking Tyra Biosciences Inc. among high performing stocks via toolsWeekly Trend Summary & Real-Time Buy Zone Alerts - Newser
Is Tyra Biosciences Inc. stock bottoming outWeekly Trade Summary & AI Optimized Trading Strategy Guides - Newser
Using Bollinger Bands to evaluate Tyra Biosciences Inc.Weekly Earnings Recap & Expert Approved Trade Ideas - Newser
Developing predictive dashboards with Tyra Biosciences Inc. dataExit Point & Smart Investment Allocation Insights - Newser
What the charts say about Tyra Biosciences Inc. todayWeekly Stock Recap & Weekly Setup with ROI Potential - Newser
What makes Tyra Biosciences Inc. stock attractive to long term investorsJuly 2025 WrapUp & Precise Entry and Exit Recommendations - Newser
How institutional ownership impacts Tyra Biosciences Inc. stockJuly 2025 Closing Moves & Free High Return Stock Watch Alerts - Newser
Combining price and volume data for Tyra Biosciences Inc.Portfolio Risk Summary & Daily Entry Point Alerts - Newser
Volume spikes in Tyra Biosciences Inc. stock – what they meanWeekly Gains Summary & Long Hold Capital Preservation Plans - Newser
What recovery options are there for Tyra Biosciences Inc.Weekly Trade Report & High Yield Equity Trading Tips - Newser
How sentiment analysis helps forecast Tyra Biosciences Inc.Buy Signal & Risk Controlled Stock Alerts - Newser
Earnings Chart Overlay Points to Tyra Biosciences Inc. UpsideWeekly Profit Analysis & Low Drawdown Momentum Ideas - beatles.ru
Will Tyra Biosciences Inc. stock benefit from AI tech trendsTrade Risk Assessment & Low Risk High Reward Ideas - Newser
Wall Street Analysts See a 178.82% Upside in Tyra Biosciences (TYRA): Can the Stock Really Move This High? - MSN
Advanced analytics toolkit walkthrough for Tyra Biosciences Inc.Analyst Upgrade & Capital Efficient Trading Techniques - Newser
What machine learning models say about Tyra Biosciences Inc.IPO Watch & Trade Opportunity Analysis - Newser
What’s Tyra Biosciences Inc.’s historical returnJuly 2025 Earnings & Free Growth Oriented Trading Recommendations - theviewers.co.kr
Tyra Biosciences shares rise 2.56% intraday after dosing first child in BEACH301 Phase 2 study for Dabogratinib. - AInvest
Tyra Biosciences begins dosing in Phase 2 trial for achondroplasia treatment - Investing.com
Tyra Bioscience Begins Phase 2 Study for Achondroplasia - TipRanks
Tyra Biosciences initiates paediatric study for achondroplasia treatment - Yahoo Finance
Unlocking the Potential of Precision Medicine: Tyra Biosciences and the Future of Dabogratinib in Pediatric Achondroplasia - AInvest
Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia - Citizen Tribune
Tyra Biosciences doses first child in achondroplasia treatment trial - Investing.com
Tyra Biosciences doses first child in achondroplasia treatment trial By Investing.com - Investing.com South Africa
Tyra Biosciences Initiates Phase 2 Study for Dabogratinib in Pediatric Achondroplasia - AInvest
Tyra Biosciences Announces Participation at Upcoming Investor Events - PrimePublishers.com
RSI Reset May Fuel Rebound in Tyra Biosciences Inc.July 2025 Patterns & Technical Confirmation Alerts - 더경남뉴스
Tyra Biosciences Inc. stock chart pattern explainedJuly 2025 Price Swings & AI Based Buy and Sell Signals - Newser
How to recover losses in Tyra Biosciences Inc. stock2025 Historical Comparison & Stock Portfolio Risk Management - Newser
Tyra Biosciences Inc Stock (TYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):